s aureus atcc 29213 qc strain (ATCC)
Structured Review

S Aureus Atcc 29213 Qc Strain, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 9738 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/qc+strains+atcc+29213/Staphylococcus+aureus%3B+subsp%2E+aureus/pmc12977467-95-23-25
Average 99 stars, based on 9738 article reviews
Images
1) Product Images from "Leveraging patient data to detect systematic shifts in daptomycin susceptibility testing associated with reduced prescribing"
Article Title: Leveraging patient data to detect systematic shifts in daptomycin susceptibility testing associated with reduced prescribing
Journal: Journal of Clinical Microbiology
doi: 10.1128/jcm.01510-25
Figure Legend Snippet: Daptomycin AST results at BJH and HUP. ( A, D ) The monthly fraction of index clinical isolates (e.g., first per patient encounter) of Enterococcus faecium, Enterococcus faecalis, Staphylococcus aureus, and Staphylococcus epidermidis and testing susceptible (S) or susceptible dose-dependent (SDD). ( B, E ) Daptomycin MIC values for index Enterococcus faecium clinical isolates. ( C, F ) Daptomycin MIC values for the Staphylococcus aureus ATCC 29213 quality control strain. In panel A, the shaded regions indicate the 95% confidence interval. In panels B and C , marker color indicates a result categorized as S or SDD (gray) or not susceptible (red), and lines and shaded regions indicate the monthly median and interquartile range (25th–75th percentile), respectively. In all panels, the vertical dashed lines represent change points determined for the data in the left side of panel A , and the triangle markers denote the timing of institution-specific daptomycin ETEST lot changes. Horizontal lines in C indicate the acceptable CLSI QC range.
Techniques Used: Control, Marker
Related Articles
AST Assay:Article Title: In vitro exebacase (CF-301) activity against methicillin-susceptible or methicillin-resistant Staphylococcus aureus and coagulase-negative staphylococci strains isolated from patients with infective endocarditis. Article Snippet: Hospital Clinic—Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), University of Barcelona, Barcelona, Spain; CIBER Thematic Area of Infectious Diseases (CIBERINFEC), Instituto de Salud Carlos III, Madrid, Spain; Biomedical Research Networking Center in Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN), Instituto de Salud Carlos III, Madrid, Spain; Microbiology, Genetics and Statistics Department, University of Barcelona, Barcelona, Spain; ContraFect Corporation, Yonkers, NY, USA; Reial Academia de Medicina de Catalunya, Barcelona, Spain Article Title: Antimicrobial Activity of Exebacase (Lysin CF-301) against the Most Common Causes of Infective Endocarditis Article Snippet: The MICs of exebacase against staphylococci were determined by broth microdilution (BMD) ( 23 ) using a nonstandard antimicrobial susceptibility testing (AST) medium comprised of cation-adjusted Mueller-Hinton broth (CAMHB) supplemented with horse serum (Sigma-Aldrich) and dithiothreitol (Sigma-Aldrich) to final concentrations of 25% and 0.5 mM, respectively. .. This medium, referred to as CAMHB-HSD, was approved for use in exebacase AST by the Clinical and Laboratory Standards Institute (CLSI) AST Subcommittee, based on the acceptance of quality control (QC) ranges determined for the Control:Article Title: In vitro exebacase (CF-301) activity against methicillin-susceptible or methicillin-resistant Staphylococcus aureus and coagulase-negative staphylococci strains isolated from patients with infective endocarditis. Article Snippet: Hospital Clinic—Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), University of Barcelona, Barcelona, Spain; CIBER Thematic Area of Infectious Diseases (CIBERINFEC), Instituto de Salud Carlos III, Madrid, Spain; Biomedical Research Networking Center in Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN), Instituto de Salud Carlos III, Madrid, Spain; Microbiology, Genetics and Statistics Department, University of Barcelona, Barcelona, Spain; ContraFect Corporation, Yonkers, NY, USA; Reial Academia de Medicina de Catalunya, Barcelona, Spain Article Title: Antimicrobial Activity of Exebacase (Lysin CF-301) against the Most Common Causes of Infective Endocarditis Article Snippet: The MICs of exebacase against staphylococci were determined by broth microdilution (BMD) ( 23 ) using a nonstandard antimicrobial susceptibility testing (AST) medium comprised of cation-adjusted Mueller-Hinton broth (CAMHB) supplemented with horse serum (Sigma-Aldrich) and dithiothreitol (Sigma-Aldrich) to final concentrations of 25% and 0.5 mM, respectively. .. This medium, referred to as CAMHB-HSD, was approved for use in exebacase AST by the Clinical and Laboratory Standards Institute (CLSI) AST Subcommittee, based on the acceptance of quality control (QC) ranges determined for the |